{
  "id": 19846621,
  "title": "Drug safety information must remain accessible as patients move from websites to AI",
  "url": "https://urgent.news/2026/11/13/drug-safety-information-must-remain-accessible-as-patients-move-from",
  "topic": "ai",
  "section": "AI",
  "published": "2026-11-13T18:20:01.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-11-drug-safety-accessible-patients-websites.html"
  },
  "original_language": "en",
  "account": "As patients increasingly rely on AI systems to find information about medications, the accessibility of drug safety information remains crucial. The challenge lies not only in the accuracy of the information but also in how it is presented across different platforms. Pharmaceutical websites, while required to present benefits and risks in a balanced manner, face design challenges in presenting this information. Long safety sections can hinder navigation, particularly on mobile devices. The FDA mandates appropriate risk disclosure but does not dictate a universal interface for presenting it. A 2017 study found that the placement of safety information on a drug website impacts how well consumers remember the risks. Websites, while controlled by pharmaceutical companies, often have issues with performance and accessibility. Even fewer pages (2.7%) met basic accessibility standards, and a significant portion (20.4%) exhibited poor visual stability. As AI technologies like Google's AI Mode and AI Overviews enter the scene, patients may encounter a blend of information from various sources. While pharmaceutical companies maintain control over their websites, AI-generated content may not preserve the same details, context, or balance between benefits and risks. This raises questions about how drug information will be evaluated and presented across multiple interfaces. It is essential to consider the broader information system involving patients, AI technologies, medical sources, and advertising platforms. Future research should focus on how AI systems maintain essential safety information, distinguish medical evidence from commercial messages, and assist patients in making informed decisions.",
  "summary": "A prescription drug warning can be accurate and still be difficult for a patient to use. What matters is not only the information itself but also how and where people receive it. This becomes especially important as patients increasingly use AI systems to find answers about medications, sometimes without visiting the original source.",
  "key_points": [
    "Drug safety info must stay accessible as patients use AI for medication info.",
    "AI systems present challenges in presenting balanced drug risk info.",
    "FDA requires risk disclosure but lacks universal interface standards."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}